Massachusetts: 90-day Supply for Certain Schedule II/III Prescriptions

MA Pharmacy Practice Resources & Guidance

Published September 5th, 2024

Detected February 12th, 2026

Summary

The Massachusetts Board of Registration in Pharmacy updated its policy to allow a 90-day supply for certain Schedule II and III prescriptions, including those for opioid use disorder treatment, non-opioid stimulants, testosterone, and implantable infusion pumps. Other Schedule II and III medications remain limited to a 30-day supply.

View original document View source feed page

What changed

The Massachusetts Board of Registration in Pharmacy has updated Policy 2024-05 to permit a 90-day supply for specific Schedule II and III prescriptions, superseding Policy 2023-06. This change, based on an update to M.G.L. 94C § 23(d), now allows for 90-day supplies for drugs treating opioid use disorder (e.g., buprenorphine), non-opioid Schedule II/III medications (e.g., stimulants, testosterone), and implantable infusion pumps. Verification of diagnoses for narcolepsy, ADD, or ADHD is no longer required for these extended supplies.

Pharmacies dispensing into, within, or from Massachusetts must adhere to this updated policy. Prescribers or authorized agents should be consulted for changes to prescriptions for federally controlled drugs. Compliance with this policy is mandatory for affected pharmacies, with no specific compliance deadline mentioned beyond the effective date of the policy update.

What to do next

Update pharmacy dispensing protocols to allow 90-day supplies for specified Schedule II/III medications.
Ensure staff are trained on the updated policy regarding quantity limits for Schedule II/III prescriptions.
Consult prescriber or authorized agent for any prescription changes to federally controlled drugs as per Board policy.

Source document (simplified)

Adopted: 9/5/24 Page 1 of 1 Board of Registration in Pharmacy Drug Control Program Policy 202 4- 05: Schedules II and III Quantity Limits Unless otherwise prohibited, M.G.L. 94C § 23(d) has been updated to allow Schedules II and III prescriptions to be written and filled for a 90-day supply for the following: 1. drugs for the treatment of opioid use disorder, such as buprenorphine products; 2. any non -opioids in Schedules II and III, such as stimulants and testosterone; and 3. implantable infusion pumps. All other Schedule II and III medications (e.g., opioids) may only be filled for a maximum 30-day supply. This change applies to all pharmacies that dispense into, within, or from Massachusetts. There is no longer a need to verify diagnoses for narcolepsy, Attention Deficit Disorder (“ADD”), or Attention Deficit/Hyperactivity Disorder (“ADHD”). Changes to prescriptions for federally controlled drugs must b e discussed with the prescriber or authorized agent. See the Board's policy on permitted prescription changes for more details. Supersedes Policy 2023- 06 Please direct any questions to: Pharmacy.Admin@mass.gov The Commonwealth of Massachusetts Executive Office of Health and Human Services Department of Public Health Bureau of Health Professions L icensure 250 Washington Street, Boston, MA 02108- 4619 KATHLEEN E. WALSH Secretary ROBERT GOLDSTEIN, MD, PhD Commissioner Tel: 617- 624 -6000 www.mass.gov/dph MAURA T. HEALEY Governor KIMBERLEY DRISCOLL Lieutenant Governor